June 4-7, 2018 | Boston, MA

Vote for the Everyday Superhero

Vote for Everyday Superheroes of Biotech!

Earlier this month, members of the biotech community nominated their best and brightest colleagues who are striving to heal, fuel, and feed the world through groundbreaking innovation. Now it is your turn to vote for your favorite BIO Superhero in each of the three categories: Biotech/Pharma, Patient/Patient Group, and University/Research Institution. One vote per email address, per day will be strictly enforced. See contest rules. The individuals with the most votes in each category will win a complimentary Convention Access pass as well as a being featured in email, on the website, and in social media! Voting is open until 11:59:59 pm ET on March 25, 2015. Winners will be announced at the 2015 BIO International Convention in Philadelphia, June 15-18.

Voting is now closed!

Thank you to the thousands of you that participated in our BIO Superhero Contest® and most importantly to all of our nominees and finalists! We are so grateful for your work and your commitment to helping others.

Stay tuned for details on the announcement of winners and you can expect to see many of the finalists in June at BIO 2015.

  • Patient/Patient Group
  • Pharma/Biotech
  • University/Research Institution
Votes
151
Nominee
#BIO2015

Nick Conley

Nick Conley

CEO | EpiBiome

Nick is an incredible leader and team player, bringing is team forward one step at a time, with a clear focus and a big vision. EpiBiome is working on phage therapy, starting in the agriculture space and moving into human health where the need for alternatives to antibiotics and new therapies to fight against antibiotic resistant microbes is huge. While starting with a narrow focus, EpiBiome is optimizing phage therapy using state-of-the art technologies including next generation sequencing, and is developing an approach that can be applicable in the near future in microbiology and in the microbiome space at large. In just one year EpiBiome moved from the prestigious Illumina accelarator to J&J Innovation labs, was admitted at the Springboard accelerator, highly vetted expert network of innovators, investors and influencers who are dedicated to building companies led by women, secured a $6M series A fund and was awarded a Bill and Melinda Gates Grand Challenge exploration grant.

Super Power:

 

Votes
341
Nominee
#BIO2015

Howard Jacob, PhD

Howard Jacob, PhD

Exec Vice President of Genomic Medicine | HudsonAlpha Institute for Biotechnology

Dr. Howard Jacob is singularly driven to harness the power of the genomic sequence to change medicine. The first person in history to use genome sequencing to diagnose, treat and cure a patient, Jacob launched the world's first genomic medicine program. At HudsonAlpha, a nonprofit research institute, he leads the genomic medicine program. "There are 35 million Americans with rare disease who need access to this potentially lifesaving technology today," he says with passion. Jacob's team has sequenced hundreds of exomes and moved into the genomic space, boosting the diagnostic rate of rare undiagnosed disease from around 6% to nearly 30%. “I always believed genomics was going to improve medicine,” he says. “But it went from being a dream to being a passion. I’m frustrated that we’re not helping more people today, when I know we could be changing lives. The good news is that we are going to be changing lives, and changing medicine, through genomics.”

Super Power:

 

Votes
26
Nominee
#BIO2015

Loretta Mayer

Loretta Mayer

CEO | SenesTech

After 20 successful years in business, Dr. Loretta Mayer was inspired by a friend’s illness to go into biotechnology. She went back to school earning both Master’s and Ph.D. degrees in Biology. She co-founded SenesTech based on a desire to create a product that would increase the quality of life for both humans and animals globaly. SenesTech’s product addresses the proliferation of rats in both urban and agricultural settings. The bait leaves rats non-reproductive; reducing their numbers without killing. Recent tests range from the NYC Subway, the transit system in Chicago, pig farms in North Carolina, and the rice fields in Southeast Asia. SenesTech partnered with the USDA at the NWRC in Colorado, on a third party study of their fertility bait. After EPA registration is complete, the path to commercialization will be accelerated by partnerships with domestic and global manufacturers, and a leading pest control company seeking alternatives to lethal methods of rodent control.

Super Power:

 

Votes
90
Nominee
#BIO2015

Jennifer Hinkel

Jennifer Hinkel

Partner | McGivney Global Advisors

Jennifer Hinkel is a Partner at McGivney Global Advisors, strategic consultants to biotech, pharma, diagnostics and health IT companies. Her areas of focus include payer and market access strategy for oncology products, innovative contracting and pricing strategies, forecasting market and revenue impact of policy and payer initiatives, value in oncology, and commercialization paths for health IT and mobile health. Areas of expertise include integrated delivery networks, oncology guidelines and pathways, physician reimbursement methods, 340B, payer messaging, patient assistance programs, and financial modeling. Jennifer has a Master's degree in International Health Policy with a focus on pharmaceutical economics from the London School of Economics; 10+ years of pharma and payer policy experience including roles at NCCN, Roche, and Genentech, and global experience in US, European, and Latin American markets. She is also a writer, speaker, competitive sailor, and cancer survivorship advocate.

Super Power:

 

Votes
10
Nominee
#BIO2015

Kenneth Shinozuka

Kenneth Shinozuka

Inventor | SafeWander™

Kenneth Shinozuka, 17, is a senior at Horace Mann School in Bronx, NY. He is an inventor, researcher, and entrepreneur whose SafeWander™ Button Sensor was released to market on November 11, 2015. Easily and securely attached to a loved one’s clothes, the Button sends an alert to caregivers’ iPhones, iPads, or iPod Touches as soon as they get up from bed, no matter how far away they are. His new SafeWander™ Button is applicable to everyone, including those who do not wear socks to sleep. SafeWander™ empowers caregivers to monitor not only wanderers but also individuals at risk of falling. An earlier sock-based version of his invention was one of the winning projects in the Google Science Fair (www.safewander.com) and was exhibited at the White House Science Fair, among many other accolades. He has spoken about his sensors at TEDYouth, the Royal Society of Medicine, and other prestigious conferences. In addition to creating healthcare innovations, Kenneth is an Eagle Scout committed to community service and an avid public forum debater passionate about global current affairs. A film buff, he serves as the Editor in Chief of his school's film magazine.

Super Power:

 

Votes
50
Nominee
#BIO2015

Dan Voytas

Dan Voytas

Chief Science Officer | Calyxt

Daniel Voytas, Ph.D., is Professor of Genetics, Cell Biology and Development at the University of Minnesota and Director of the Beckman Center for Genome Engineering. He is also the Chief Scientific Officer of Calyxt, an agricultural biotechnology company focused on developing crops that provide consumer benefit. Dan is best known for his pioneering work to develop methods for precisely altering DNA sequences in living cells, enabling detailed functional analysis of genes and genetic pathways. Dan's work has enabled efficient methods for targeted genome modification of plants using sequence-specific nucleases. Using zinc finger nucleases (ZFNs), TAL effector nucleases (TALEN®), and the CRISPR/Cas9 system, Dan has achieved targeted gene knockouts, replacements and insertions in a variety of plant species. This type of targeted genome modification has applications ranging from understanding plant gene function to developing crop plants with new traits of value.

Super Power:

 

Votes
58
Nominee
#BIO2015

Emil Kakkis, MD, PhD

Emil Kakkis, MD, PhD

Advocate | EveryLife Foundation for Rare Diseases

Dr. Emil Kakkis has given longer life and hope to many suffering from rare diseases. Starting out as an unknown researcher struggling for project funding, he led the creation of first treatments for the rare diseases, MPS I, MPS IV, MPS VI, and PKU. He is the scientific innovator behind the establishment of two successful rare disease drug development companies, BioMarin and Ultragenyx, a company he founded. Ultragenyx has grown to over 160 employees, is listed on the NASDAQ Global Select Market and has a market capitalization of approximately $3 billion. Ultragenyx is developing five molecules for seven rare diseases. Three products are in or entering the final stages of clinical development. Dr. Kakkis is a thought leader driving improvements to the processes of drug development through public policy advocacy on Capitol Hill. He founded The EveryLife Foundation for Rare Diseases and Rare Disease Legislative Advocates creating a community of rare disease advocates and drug developers that work hard to define what is wrong with drug development processes in the U.S., and what can be done to fix it. Dr. Kakkis focuses his work on diseases that few others would consider due to the difficulties and financial risks involved in trying to help small patient populations with complex and devastating disease. As a result of his efforts, there are a many patients today living longer, and with a higher quality of life, who otherwise would not have any treatments at all.

Super Power:

 

Votes
237
Nominee
#BIO2015

Charles A. Mohan, Jr.

Charles A. Mohan, Jr.

CEO/Executive Director | United Mitochondrial Disease Foundation

Chuck Mohan and his wife Adrienne lost their daughter Gina at the age of 15 to mitochondrial disease. Chuck decided not to become a victim of the disease, but part of the search for a cure. There was very little information about the disease. More critically, there were very few medical experts that heard about mitochondrial disease. In 1996, he started the United Mitochondrial Disease Foundation (UMDF) in the basement of his Monroeville, PA home. In the past 20 years, UMDF is now internationally recognized as the leading patient advocacy group for these patients. His efforts to grow the UMDF has enabled the organization to fund more than $13 million in research. He’s put together a Grand Rounds program at hospitals both large and small, so that medical experts can learn about this complex disease. He’s also carried his message to Washington, DC. A Congressional Mitochondrial Disease Caucus was formed to educate lawmakers about mitochondrial disease.

Super Power:

 

Votes
68
Nominee
#BIO2015

Claire Wineland

Claire Wineland

FOUNDER | CLAIRE'S PLACE FOUNDATION

Claire’s Place Foundation, Inc. is a 501c3 non-profit organization providing support to children and families affected by cystic fibrosis (CF). Claire’s Place Foundation is named in honor of Claire Wineland, now a teenager, who has been living with CF her entire life. The foundation provides grants to families affected by CF, offering both emotional and financial support. A young author of bestseller “Every Breath I Take, Surviving and Thriving with Cystic Fibrosis,” Claire’s unique inspirational model for people living with this disease has led her to be a TEDx Speaker and receive multiple awards including Fox Teen Choice Awards 2015, Gloria Barron Prize for Young Heroes, Southbay Magazine’s “Top 10 South Bay Teen”, Looking Beyond LA’s “Soaring Spirit Award,” and winner of Los Angeles Business Journal’s “Small Nonprofit of the Year.” She has been featured on Inside Edition, The Dr. Oz Show, CNN, Huffington Post, ABC News, Cosmopolitan, People, Ladies’ Home Journal and more. Claire’s Place Foundation is a way for Claire to give back with hope, strength, and joy and make meaning of what she has had to go through.

Super Power:

 

Votes
0
Nominee
#BIO2015

Igor Fisch

Igor Fisch

CEO | Selexis

For the past 15 years, Igor Fisch, CEO and co-founder of Selexis, has been shaping the future of recombinant protein expression/cell line development for therapeutic protein production. This started in 2001 with the introduction of Selexis’ MAR (matrix attachment region)-based technology, which reduced cell line development times by 60-75% and boosted productivity to g/L levels, values virtually unheard of at that time and launched 15 years of innovation in which Igor and his Selexis team have improved on virtually every aspect of protein expression cell line development from DNA transfection to optimizing the secretory processes of their production CHO cell lines, driving higher expression levels of even more complex and promising therapeutics. With over 140 patents and growing, Igor intends to continue to push the envelope of what production cell lines can achieve and to generate a fully virus free CHO cell line bringing an added measure of safety to the manufacturing process.

Super Power:

 

Votes
113
Nominee
#BIO2015

Robert Walsh

Robert Walsh

Robert Walsh, Senior Vice President, Energy Sector | Intrexon Corporation

Mr. Walsh has more than 35 years of global petroleum and chemical industry experience, including 26 years at Royal Dutch Shell. Mr. Walsh has been a bio-based economy champion for the past ten years in his current role and previously as the President of LS9, CEO of Aurora Biofuels and Chief Commercial Officer for ZeaChem. Under his leadership Intrexon is developing a breakthrough bio-based gas to liquids platform to convert abundant low cost methane to fuels, lubricants and chemicals. This platform starts with engineering methane-consuming bacteria to deliver these compounds. The team has developed techniques generating this bacteria to be as genetically manipulative as yeast or e. coli, two proven industrial biotechnology platforms, but with higher efficiency and without the food versus fuel discussion.

Super Power:

 

Votes
153
Nominee
#BIO2015

Kavita Shukla

Kavita Shukla

Founder | Fenugreen

Kavita's simple innovation, FreshPaper (which keeps food fresh 2-4x longer, naturally) could help address some of the greatest challenges we face today: food security, hunger, diet-related disease, and poverty. Over one third of our world's food supply is lost to spoilage, while over 800 million are food insecure due to inefficiencies in food distribution. Kavita's work is changing mindsets to empower consumers, large-scale growers, and subsistence farmers in the developing world to reduce waste and improve yields.

Super Power:

 

Votes
55
Nominee
#BIO2015

Alison Van Eenennaam

Alison Van Eenennaam

Animal Biotechnology and Genomics Specialist | University of California, Davis

Dr. Van Eenennaam’s research program at UC Davis is at the forefront of animal biotechnology. She has served on national committees including the USDA AC21, and the 2010 FDA AquAdvantage salmon VMAC. However it is in her capacity as a scientific communicator that she is a true future maker. She is a mover and shaker on a variety of issues related to regulation and public acceptance of animal biotechnology, especially as it pertains to global food and feed. She has given over 400 invited presentations nationally and internationally, and has provided a credentialed voice in national media including the Dr. Oz Show, NPR, and Intelligence Squared. Her engaging manner, humor and use of media (including parody videos) make her unparalleled in relating to audiences. She believes in the use of technology in agricultural production systems, and her scientific communication and educational efforts have been pivotal in advancing animal biotechnology innovations.

Super Power:

 

Everyday Superhero Contest Rules
X

Thank You

Thank you for nominating your Everyday Superhero! Spread the word by sharing your nomination on the social networks below.

X

One Last Step...

Thank you for voting for Everyday Superhero! You will receive an email at the address you submitted your vote. Follow the steps in the email to make your vote count.

X

Your Vote Has Been Verified

Thank you for voting for the Everyday Superhero! Your vote has now been verified. Remember, your vote only counts once a day, so be sure to return each day to vote!

X

Thank You

Thank you for voting for the Everyday Superhero! Unfortunately, your votes only count once a day. Be sure to return tomorrow to vote again!

X

Contest Rules

2015 BIO® Superhero Contest

NO PURCHASE NECESSARY TO ENTER OR WIN.

Purchasing Will Not Increase Your Chance Of Winning.
Many Will Enter, Few Will Win.

1. Eligibility:
Entry Submission in the 2015 BIO® Superhero Contest (hereafter, "Contest") is open only to those individuals who have reached the age of majority in their jurisdiction of residence at the time of entry. Employees of the Biotechnology Industry Organization (hereinafter, “BIO” or “Sponsor” or “Administrator” or “Released Parties”), and their immediate family members (spouse, parent, child, sibling and their respective spouses, regardless of where they live) or persons living in the same households of such employees, whether or not related are not eligible. CONTEST IS VOID WHERE PROHIBITED.

2. Contest Submission Period:
The Contest submission period starts at 5:00:00 pm Eastern Time ("ET") on 2/19/2015 and ends at 11:59:59 pm ET on 3/05/2015 (hereafter, "Contest Submission Period").

3. Contest Voting Period:
The Contest voting period starts at 6:00:00 am ET on 3/18/2015 and ends at 11:59:59 pm ET on 3/25/2015 (hereafter, "Contest Voting Period").

4. How To Enter the Contest:
To participate, visit www.convention.bio.org/superhero (hereafter, "Site") using your personal computer or mobile device during the Contest Submission Period and follow the prompts to do all of the following to complete and submit the registration form inclusive of one (1) or more of the below Submission Types depicting the Contest's theme defined as follows (hereafter, each the "Theme"):

1.    For entrants submitting a nominee in the Patient/Patient Group Category: individuals that through their own personal journey or advocacy efforts have raised awareness for a specific patient community.

2.    For entrants submitting a nominee in the Pharma/Biotech Category: employees in the life science industry who have been instrumental in advancing therapies for patients.

3.    For entrants submitting a nominee in the University/Research Category: researchers or scientists in academia who have been instrumental in researching or advancing therapies for patients.

Submission Types:

1.    Essay: up to five hundred (500) characters.

If you choose to enter using your mobile phone, standard data fees may apply. See your wireless provider for pricing plan details.

The submitted essay combined with the associated registration form are hereafter each referred to as an "Entry". Limit one (1) Entry per person and per email address per Category for the duration of the Promotion Period. In case of multiple Entries from any one person or email address in a specific Category, only the first Entry received in such Category will be accepted. All Contest Entries must meet the Contest Entry Requirements set forth below. Entries must be submitted and received during the Contest Submission Period.

Contest Entry Requirements: By entering the Contest, each entrant warrants and represents that his/her Entry is original, does not contain any material that would defame or otherwise violate or infringe upon the rights of any third party, including patents, copyrights, trademarks or rights of privacy or publicity, and will not violate any federal, state or local laws or ordinances. Entrants further warrant and represent that they have secured the requisite consent from any third party appearing or referenced in their Entries.

Incomplete Entries and/or Entries containing inaccurate entrant information will be disqualified at Sponsor's sole discretion. The use of script, macro or any other device to automate or subvert the entry process is prohibited and all such Entries and Entries made by any other means which subvert the entry process will be void. In the case of a dispute as to the entrant who submitted an Entry, Entry will be deemed made by the person named on the applicable registration form (regardless of whether that is the name of the authorized account holder of the email address from which said Entry was submitted) and he/she must comply with these Official Rules. Other than as otherwise specified herein, neither Sponsor, nor anyone acting on its behalf, will acknowledge any Entry (or portion thereof) received. Any Entry not meeting all Entry requirements stated herein will be void.

Entries deemed by the judges, in their sole discretion, to be immoral, obscene, profane or not in keeping with Sponsor's image and values or in violation of these Official Rules will be void. In the event of non-compliance with any requirements specified herein or with any of the terms of these Official Rules, Entry will be void.

If the Entry contains any material or elements that are not owned by the entrant, and/or which are subject to the rights of third parties, the entrant is responsible for obtaining, prior to submission of the Entry, any and all releases and consents necessary to permit the use and exhibition of the Entry by Sponsor in the manner set forth in these Official Rules, including, without limitation, name and likeness permissions from any person who appears in or is identifiable in the Entry.

Sponsor reserves the right to request proof of these permissions in a form acceptable to Sponsor from any entrant at any time. Failure to provide such proof may, if requested, render Entry null and void. By submitting an Entry, entrant warrants and represents that he/she and any persons who are identifiable in the Entry consent to the submission and use of the Entry in the Contest and to its use as otherwise set forth herein.

By submitting an Entry, entrant hereby (i) grants the Released Parties, without any limitation of any other rights granted herein, permission for the Entry to be posted on the Site and any other media platform as determined by Sponsor in its sole discretion; (ii) acknowledges and agrees that his/her Entry may be shared via social media by third parties; and (iii) agrees that Released Parties are not responsible for any unauthorized use of Entries by third parties. Released Parties do not guarantee the posting of any Entry and may remove a posted Entry at any time.

By submitting an Entry, entrant acknowledges and agrees that Sponsor may obtain many submissions under this Contest and that such Entries may be similar or identical in theme, idea, format or other respects to others submitted under this Contest and/or other Contest staged and/or sponsored by the Sponsor, or to other ideas conceived by or provided to Sponsor and entrant waives any and all claims entrant may have had, may have, and/or may have in the future, that any Entry and/or other works accepted, reviewed and/or used by the Sponsor (or its designees) may be similar to his/her Entry. Except where prohibited by law, each entrant acknowledges and agrees that the Sponsor does not have now, nor shall it have in the future, any duty or liability, direct or indirect, vicarious, contributory, or otherwise, with respect to the infringement or protection of any copyright in and to entrant's Entry or any other right related thereto.

5. Entry Judging:
Round 1 of Judging: All eligible Entries received during the Contest Submission Period  will be aggregated by Category and will be judged based on the following criteria by Sponsor (hereafter, the "Judging Criteria"):

1) Story: Does the Entry tell a story that captivates its audience:

0-5 points

2) Passion: Does the Entry stir emotion in those that watch/see/read it:

0-5 points

3) Relevance: Does the Entry meet the criteria of what is being asked

0-5 points

4) Sense of Community: Is the Entry something that people will want to share with their digital community:

0-5 points

5) Unique: Does the Entry resonate in a rare and special way:

0-5 points

 

Round 1 of Judging will take place between 3/05/2015 and 3/11/2015.  In the event of a tie during Round 1, the tied Entries will be re-judged based on: Relevance: Does the Entry meet the criteria of what is being asked: 0-100 points. By participating, entrants agree to abide by these Official Rules and the decisions of the Sponsor and judges, which are final and binding in all matters relating to this Contest. 

The five (5) Entries in each respective Category with the highest scores during Round 1, as determined in Round 1 of the judging by the judges in their sole discretion, will be deemed the "Potential Finalists" and advance to the Contest Voting Period. Sponsor and judges reserve the right to advance fewer than five (5) Entries in any Category to the Contest Voting Period if, in their sole discretion, they do not receive a sufficient number of eligible and qualified Entries in the respective Category.

Upon verification of the Finalists (as outlined in section 6 below), representatives of the Biotechnology Industry Organization will notify the submitting entrant and the Finalists will advance to the Contest Voting Period.  Finalists agree that the Biotechnology Industry Organization shall have full creative authority over the development and creation of the Finalist Entries and that Finalists will not have the opportunity to review or request revisions of the Finalist Entry.

6. Finalist Notification:
Potential Finalists will be selected on or about 3/11/2015 and will be notified approximately between 3/11/2015 and 3/16/2015 by telephone, email, overnight mail and/or in person. Potential Finalists will be required to (i) execute and return an Affidavit of Eligibility, Liability and (where legal) Publicity Release; (ii) if child/legal ward is the subject of the Entry, execute and return a Liability and Publicity (where legal) Release on behalf of such child/legal ward; and (iii) for any minors depicted in the Entry, secure and return a Liability and Publicity (where legal) Release from each such minor's parent or legal guardian with any other documents required by Sponsor within two (2) days of date of issuance of notification.

Further proof or verification of identity and qualifications may be required along with a background check and entrant (and his/her parent/legal guardian as applicable), by participating, agrees to such check and agrees to provide full consent if required. Failure to comply may result in disqualification and, based on the criteria described above and time permitting, selection of another Finalist to compete in the Contest Voting Period. In addition, at the discretion of the Sponsor, potential Finalist(s) may be disqualified for any of the following, without limitation: if charged with or convicted of a felony or misdemeanor, is not eligible based on the eligibility requirements set forth above, or if delinquent on a government ordered payment, such as but not limited to: child support, spousal support, alimony, tax payments, etc. Noncompliance with any of the foregoing, with these Official Rules, the inability to contact a potential Finalist within a reasonable time period, the failure to complete and return requested documentation in a timely manner, or any notification being returned as non-deliverable may result in disqualification and, at Sponsor's discretion, a runner-up being chosen. Finalist status is subject to verification of eligibility and compliance with these Official Rules.

Finalists' Entries will be posted on the Site during the Contest Voting Period as outlined below.

7. Contest Voting Period:
During the Contest Voting Period, each of the Finalist Entries will be posted on the Site for public voting. To vote for a Finalist Entry in each of the three (3) Categories, during the Contest Voting Period, eligible individuals 13 years of age or older may visit the Site using a computer or mobile device and following the instructions provided, view each of the Finalist Entries in the three (3) Categories and click on the applicable "Vote" button to cast your vote for your favorite Finalist Entry in each Category. Limit one (1) vote submission per email address per Category per day. Additional votes received from the same email address in excess of the stated daily limitation will be void.

At the conclusion of the Contest Voting Period, the one (1) Finalist Entry in each of the individual Categories that received the highest number of votes will be deemed the Individual Grand Prize winner for their respective Category.  In the event of a tie in any Category during the Contest Voting Period, the tied Finalist Entries in such Category will be re-judged (by a panel of judges determined by Sponsor in its sole discretion) based on: Relevance: Does the Entry meet the criteria of what is being asked: 0-100 points. Winner status is subject to verification of eligibility and compliance with these Official Rules.

All vote counting will be conducted at the direction, and in the sole discretion, of the Sponsor. The use of automated devices (or any other devices intended to automate or subvert any aspect of entry or voting or any other procedure that subverts the entry process) to cast a vote is prohibited and any Entry or vote through such means will, at Sponsor's sole discretion, be void. Sponsor reserves the right, in its sole discretion, to void any votes of entrants whom Sponsor believes has attempted to tamper with or impair the administration, security, fairness or proper play of this Contest or is in violation of these Official Rules. Finalists are prohibited from obtaining votes by any fraudulent or inappropriate means, including, without limitation, offering prizes or other inducements to members of the public and/or using any websites or online forums designed to induce individuals or provide other incentives to vote for their Finalist Entry, as determined by Sponsor in its sole discretion.

8. Prizes:
Three (3) Individual Grand Prizes: The three (3) Grand Prize winners will each receive up to two (2) Convention Access registrations (up to $3,398 in value) to the 2015 BIO International Convention (“Convention”), which will be held in Philadelphia, Pennsylvania, June 15-18, 2015.  Taxes on prizes are solely the responsibility of the winner.  The prize is not redeemable in cash and must be accepted as awarded.

If, for any reason, a Grand Prize winner cannot accept one of the grand prizes, the Sponsor shall have no further obligation to the Grand Prize winner. All other expenses relating to acceptance of Grand Prize not explicitly stated herein, including but not limited to travel costs, hotel expenses, taxes, ground transportation, meals, beverages, and gratuities or any other miscellaneous travel expenses are the responsibility of Grand Prize winner.  Specifics of the Grand Prize are subject to availability and Sponsor's sole discretion. Prize is non-transferable.

The registration awarded to a Grand Prize winner will become responsibility of the winner upon possession of same and will not be replaced. The terms and conditions of the registration awarded as a prize will govern in the event that the Convention is unable to take place as planned, is cancelled or postponed, for any reason whatsoever, including an event of force majeure. Sponsor has no responsibility to the winner except to provide the registration, and the registration shall constitute full satisfaction of Sponsor's prize obligation to the Prize winner, and no other compensation will be awarded.

The Sponsor reserves the right to remove or to deny entry to any winner who engages in an unprofessional or disruptive manner, or with intent to annoy, abuse, threaten or harass any other person at the Convention. The Approximate Retail Value (ARV) of each registration is $1,699.  Approximate retail value of all prizes is $10,194.  A 1099 tax form will be issued in the amount of the prize package to the applicable winners.

9. Miscellaneous; Release and Limitations of Liability:
Message and data rates may apply if you choose to enter or vote using your mobile device. To participate, in either the Contest Submission Period or Contest Voting Period, and ensure web browser compatibility, you must have the latest version of a modern browser including Internet Explorer 9+, or the latest version of Firefox, Chrome, Safari, or Opera, and JavaScript must be enabled within your browser preferences. Mobile browser compatibility includes default browsers on iOS 6 (or higher) and Android. Entrants agree, by entering, that 1) Sponsor, and its designees, may use (unless prohibited by law), entrant's name, city and state of residence, Entry, Finalist Entry, photograph, and/or likeness for advertising, trade and/or any other purposes in any media (including but not limited to websites and/or social media platforms) now or hereafter known throughout the world in perpetuity, without further compensation, permission or notification, and 2) the Released Parties shall have no liability and will be held harmless by entrant for any claim, action, liability, loss, injury or damage to entrant or any other person or entity, including, without limitation, personal injury or death to entrant or any other person or damage to personal or real property, due in whole or in part, directly or indirectly, by reason of the acceptance, possession, use or misuse of any prize or any travel/activity related thereto or participation in this Contest or the use of any Entries or Finalist Entries by Sponsor, its designees or any third party.

Sponsor reserves the right, in its sole discretion, to modify, terminate or suspend this Contest (or any portion thereof) should virus, bugs, non-authorized human intervention or other causes corrupt or impair the administration, security, fairness or proper play of the Contest (or any portion thereof) and, in the event of termination, at its discretion, select the Finalists and/or prize winners (as applicable) for each Category from those eligible, non-suspect Entries or Finalist Entries (as applicable) received prior to event requiring such termination using the applicable judging procedure/winner selection outlined herein and eligible, non-suspect votes as applicable.

License/Use of Entries: By entering, and to the extent allowed by law, entrants warrant and represent that Sponsor and each of their respective designees shall have a perpetual, worldwide, royalty-free, non-exclusive, sub licensable, unconditional and transferable license to edit, adapt, modify, publish, exploit and use their Entry (and all material embodied therein) in any way and in any and all media now known (including, but not limited to, online, in social media) or hereinafter discovered or devised, world-wide for trade, advertising, promotional, public relations and/or other purposes as Sponsor and/or its designees may determine without further permission from, or notification or consideration to entrants or any third parties.

Entrants further agree to abide by these Official Rules and the decisions of the Sponsor and judges, which shall be final and binding. Entrant's submission of an Entry and/or vote constitutes his/her representation of eligibility, consent to participate in Contest and consent for Sponsor to obtain, use, and transfer his/her name, address and other information for the purpose of Contest administration. Released Parties are not responsible for lost, incomplete, invalid, unintelligible, inaccurate, undeliverable, garbled, late, stolen, damaged or misdirected Entries, Finalist Entries or votes, all of which will be disqualified; failures or malfunctions of phones, phone lines or telephone systems or other communications or malfunctions; interrupted or unavailable network, server, cable, satellite, Internet Service Provider (ISP) or other connections; miscommunications, failed computer hardware or software or other technical failures; garbled, lost, misrouted or scrambled transmissions; any error, omission, interruption, defect or delay in any transmission or communication; traffic congestion on the Internet or for any technical problem, including but not limited to any injury or damage to entrants' or any other person's computer related to or resulting from participation in the Contest; theft, destruction or unauthorized access to, or alteration of, Entries, Finalist Entries or votes; the creation and production of Finalist Entry or human-processing error; printing, typographical or other errors or omissions in these Official Rules or in any Contest-related advertisements or other materials; or other errors or problems of any kind whether mechanical, human, technical, network, electronic; or errors which may occur in connection with the administration of the Contest, the incorrect uploading of Entries, the processing or judging of Entries, creation and production of Finalist Entries or the tabulation of votes, the awarding or announcement of the winners or Finalists or in any other Contest-related materials.

Sponsor reserves the right to void and remove any and all Entries and/or Finalist Entries of an entrant or votes of a voter who Sponsor believes has attempted to tamper with, influence, or impair the administration, security, fairness, judging or proper play of Contest and such entrant/voter will be disqualified and all associated Entries, Finalist Entries and/or votes will be void. All Entries (including Finalist Entries) become property of Sponsor and will not be returned. CAUTION: ANY ATTEMPT TO DELIBERATELY DAMAGE ANY WEBSITE OR UNDERMINE THE LEGITIMATE OPERATION OF THE CONTEST IS A VIOLATION OF CRIMINAL AND CIVIL LAWS AND SHOULD SUCH AN ATTEMPT BE MADE, THE SPONSOR RESERVES THE RIGHT TO SEEK ANY AND ALL REMEDIES AVAILABLE FROM ANY SUCH PERSON(S) FOR THE ATTEMPT TO THE FULLEST EXTENT PERMITTED BY LAW.

10. Arbitration:
Except where prohibited by law, as a condition of participating in this Contest, participant agrees that (1) any and all disputes and causes of action arising out of or connected with this Contest, or any prizes awarded, shall be resolved individually, without resort to any form of class action, and exclusively by final and binding arbitration under the rules of the American Arbitration Association and held at the AAA regional office nearest the entrant; (2) the Federal Arbitration Act shall govern the interpretation, enforcement and all proceedings at such arbitration; and (3) judgment upon such arbitration award may be entered in any court having jurisdiction. Under no circumstances will participant be permitted to obtain awards for, and participant hereby waives all rights to claim, punitive, incidental or consequential damages, or any other damages, including attorneys' fees, other than entrant's actual out-of-pocket expenses (i.e., costs associated with participating in this Contest), and entrant further waives all rights to have damages multiplied or increased.

11. Choice of Law:
All issues and questions concerning the construction, validity, interpretation and enforceability of these Official Rules, or the rights and obligations of participant and Sponsor in connection with the Contest, shall be governed by, and construed in accordance with, the substantive laws of the District of Columbia, USA.

12. Winner's List:
For the names of the winners (available after 4/1/15), send a self-addressed, stamped envelope to be received by 2/9/15 to: the Biotechnology Industry Organization, 1201 Maryland Avenue SW, Suite 900, Washington, D.C. 20024, USA. Attn: Marketing Department.

Sponsor/Administrator: the Biotechnology Industry Organization, 1201 Maryland Avenue SW, Suite 900, Washington, D.C. 20024, USA.

Thank you to our 2017 Sponsors

Double Helix Sponsors

Helix Sponsors

Premier Sponsors